Abstract:Aim: Recently, many international scholars of transplantation immunology have found that the soluble CD30 can be used as a new predictor for the risk related to the survival of transplanted kidney. This study is designed to investigate the association of genetic polymorphism in CD30 gene promoter region and 5′-flanking region with chronic renal failure (CRF), and explore its correlation with the increased content of soluble CD30 in the serum of CRF patients and acute rejection reaction after renal transplantation. Methods: Subjects included 78 CRF patients at final stage and 95 healthy individual controls, with their informed consents. All the patients underwent renal transplantation for the first time in Nanjing Drum Tower Hospital from May 2004 to April 2006. Peripheral white blood cell DNA was obtained from all subjects. DNA fragments in -201G/A of CD30 gene promoter region with an accession number of AJ289159 and 5′-flanking region (rs1208993 and rs946461) were detected with polymerase chain reaction. CD30 genetic polymorphism was analyzed using high-performance liquid chromatography, and the exaction of CD30 gene was verified by DNA sequence. The frequency of CD30 genotype in CRF patients and healthy controls was examined to determine the correlation between CD30 genetic polymorphism and CRF. The serum content of soluble CD30 in CRF patients was also tested to determine the association between CD30 genetic polymorphism and the content of soluble CD30. Results: All the subjects were involved in the result analysis. 1 No nucleotide mutation of -201 (AJ289159) of CD30 gene promoter region was found in all 173 cases. 2 The dimorphism frequency of the two sites (rs946461 and rs1208993) in 5′-flanking region were high in CRF patients and healthy controls, but there was no significant difference of polymorphism distribution between the two groups (P > 0.05). 3 Compared with the controls, there was a significantly higher concentration of soluble CD30 in the serum of CRF patients. Conclusion: The genetic polymorphism in the promoter and 5′-flanking region of the CD30 gene might not be associated with the increase of soluble CD30 concentration in serum of CRF patients, which may vary on the gene level or result in the immunological activation by other stimulation factors, so as to influence the rejection reaction after renal transplantation and long-term survival of transplanted kidney.

[Evaluation of Immune Status of Kidney Transplant Recipients by Combined HLA-G5 and Scd30].

High Serum Level of the Soluble CD30 Identifies Chinese Kidney Transplant Recipients at High Risk of Unfavorable Outcome

[Influence of Pre-Transplant Serum Level of Soluble CD30 on the Long-Term Survival Rates of Kidney Transplant Recipients and Grafts].

Acute rejection episodic outcomes resulted from pre-transplant serum level of the soluble CD30 in kidney transplant recipients

Diagnosis Value of the Expression of CD44 in Acute Rejection after Human Liver Transplantation

Relationship between acute rejection in kidney transplantation and expression of sCD30

The difference of ELISA and LABScreen in detecting HLA antibodies

Clinical Analysis of 2520 Renal Transplantations in One Center

Application of immune cell functional assay in monitoring immune status in renal transplant recipients

Preliminary Investigation of the Biomarkers of Acute Renal Transplant Rejection Using Integrated Proteomics Studies, Gene Expression Omnibus Datasets, and RNA Sequencing.

Soluble CD30, the Immune Response, and Acute Rejection in Human Kidney Transplantation: A Systematic Review and Meta-Analysis

Effect of acute humoral rejection on renal allograft survival

Impact of Alloantibody Strength in Crossmatch Negative DSA Positive Kidney Transplantation

Association of CD30 genetic polymorphism with chronic renal failure and acute rejection reaction after renal transplantation

Landscape of the immune infiltration and identification of molecular diagnostic markers associated with immune cells in patients with kidney transplantation

Evaluation of CD20 Cell Infiltration and HLA-DR Express on Outcome of Renal Graft in Patients with Acute Rejection

Association of Pre-Transplant Serum Level of Anti-Endothelial Cell Antibody with Acute Rejection in Kidney Transplant Recipients

Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

Identification of PDCD1 As a Potential Biomarker in Acute Rejection after Kidney Transplantation Via Comprehensive Bioinformatic Analysis

Monitoring of human cytomegalovirus infection in bone marrow and liver transplant recipients by antigenaemia assay and enzyme-linked immunosorbent assay.

C4d as a significant predictor for humoral rejection in renal allografts.